Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2020 | Story Thabo Kessah
Prof Moffett’s latest offering collates hundreds of mountain research material into one accessible reference book.

Prof Rodney Moffett recently published a new book focusing on various scientific articles published between 1808 and 2019. The book, A Scientific Bibliography of the Drakensberg, Maloti and Adjacent Lowlands, has 534 pages and covers material appearing in accredited journals, plus unpublished but traceable reports, documents, presentations, and dissertations.

“The scientific articles range from palaeobotany with 17 entries, to rock art with 502 entries, as well as 252 theses and dissertations,” said Prof Moffett.

He said it took 18 months to compile the book, typing the manuscript himself – mostly at night.

In the foreword, Dr Ralph Clark, Director: Afromontane Research Unit (ARU), says: “This bibliography is a labour of love, and will inspire a new generation to take up the baton for excellent research in this fantastic mountain system. We are proud to publish this under the ARU banner as a contribution to growing and consolidating mountain-passionate relationships in Southern Africa, and to encourage our journey towards developing a holistic understanding and sustainable use of these iconic mountain landscapes.” 

Other books

Prof Moffett is an honorary research fellow in the Department of Plant Sciences at the University of the Free State, and an associate of the Afromontane Research Unit on the UFS Qwaqwa Campus. He was previously Professor of Botany on the Qwaqwa Campus when it was part of the University of the North, retiring in 2000. Since then, he has remained active, publishing scholarly works on ethnobotany and other natural history subjects.

His four recent books, also published by Sun Press, are: Sesotho Plant and Animal Names and Plants used by the Basotho (2010), A Biographical Dictionary of Contributors to the Natural History of the Free State and Lesotho (2014), Basotho Medicinal Plants – Meriana ya Dimela tsa Basotho (2016), and A Field Guide to the Clarens Village Conservancy (2018). A second revised edition of Meriana ya Dimela tsa Basotho – 

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept